Mannatech results
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement direct seller reports consolidated net sales increase of 35.6% to $191 mil. in 2003, as income more than tripled over the prior year to $8.8 mil. Coppell, Texas-based company recorded sales of $54.3 mil. in the fourth quarter, up 9.2% over same period in 2002. Mannatech attributes improved annual performance in part to antioxidant product Ambrotose AO, launched last September (1"The Tan Sheet" Nov. 17, 2003, In Brief). Firm plans launches in South Korea in second half of 2004 and Taiwan in first quarter 2005...
You may also be interested in...
Mannatech
September launch of Ambrotose A.O. antioxidant supplement helps boost revenues 44.1% to $49.7 mil. for the third quarter ended Sept. 30 versus the prior-year period, Coppell, Texas-based direct marketer reports Nov. 7. CEO Sam Caster believes the product could total 25% of Mannatech's gross sales by 2005 (1"The Tan Sheet" Aug. 25, 2003, p. 15). Mannatech's net income rose to $2.9 mil. compared with $200,000 in the year-ago period...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.